The Pelvic Floor Function and Sexual Life of the Women After Different Type of Hysterectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-31

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this prospective, comparative non-randomized multiple teaching hospitals study, the investigators try to determine the relationship of total hysterectomy and Taiwanese female pelvic floor and sexual function from the view of epidemiology and clinical survey. This is an important issue that related to female autonomy, health care resources and even national health policy. The study results will help to understand whether there is unnecessary part in the current hysterectomy procedures and its potential health hazard.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Health-Related QoL Among Women Receiving Hysterectomy in NTUH

NCT00155870

Leiomyoma Adenomyosis

UNKNOWN

Concomitant Posterior Colporrhaphy on Bowel Functions in Pelvic Organ Prolapse Repair

NCT06128291

Prolapse; Female

COMPLETED

Female Sexual Function After Cystectomy

NCT04592848

Sexual Activity

COMPLETED

Goal Achievement and Patient Satisfaction in Benign Hysterectomy

NCT02621710

Hysterectomy Goal Achievement Patient Satisfaction +1 more

COMPLETED

Postoperative Urinary Retention and Urinary Track Infection (UTI) After Laparoscopic Assisted Vaginal Hysterectomy (LAVH) for Benign Disease

NCT00564135

Hysterectomy Urinary Retention Urinary Tract Infection

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women with benign gynecology disease and indicated for laparoscopic hysterectomy (laparoscopic subtotal hysterectomy: LSH, laparoscopic cervical ligament sparing hysterectomy: CLSH, laparoscopic assisted vaginal hysterectomy: LAVH) are invited and explained the details of the protocol by the surgeon. The types of hysterectomy are determined by the patient and the surgeon together after discussion. All participant have to sign the informed consent. The participant will be followed up for two years after surgery. Preoperative evaluation on uterine condition, pelvic floor, questionaires were recorded. The perioperative parameters including surgical time, blood loss, and postoperative parameters such as pain score, hospitalization etc were recorded. The postoperative evaluation on pelvic floor condition, questionaires etc were also recorded at different time points.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Quality of Life Urinary Incontinence Pelvic Organ Prolapse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Laparoscopic subtotal hysterectomy

women with benign gynecology disease and decided to receive laparoscopic subtotal hysterectomy (LSH) after discussion with her surgeon.

LSH

Intervention Type PROCEDURE

laparoscopic subtotal hysterectomy: LSH

Laparoscopic CLSH

women with benign gynecology disease and decided to receive laparoscopic cervical ligament sparing hysterectomy (CLSH) after discussion with her surgeon.

CLSH

Intervention Type PROCEDURE

laparoscopic cervical ligament sparing hysterectomy: CLSH

Laparoscopic AVH

women with benign gynecology disease and decided to receive laparoscopic assisted vaginal hysterectomy (LAVH) after discussion with her surgeon.

LAVH

Intervention Type PROCEDURE

laparoscopic assisted vaginal hysterectomy: LAVH

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LSH

laparoscopic subtotal hysterectomy: LSH

Intervention Type PROCEDURE

CLSH

laparoscopic cervical ligament sparing hysterectomy: CLSH

Intervention Type PROCEDURE

LAVH

laparoscopic assisted vaginal hysterectomy: LAVH

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

laparoscopic subtotal hysterectomy: LSH

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

1. Suspect of or diagnosed as cancer patient
2. Age \< 30 or \> 50 years old
3. Menopausal woman or woman who is nulliparous
4. Patient with advanced pelvic floor prolapse (stage 2, 3, 4) including uterine prolapse, cystocele, enterocele, rectocele.
5. Patient with prominent urinary incontinence that affect social activity or suggested to have surgery by gynecologist or urologist.
6. Patient with severe medical diseases such as liver cirrhosis, heart failure, poor control diabetes mellitus etc.
7. Patient with severe pelvic inflammatory disease/tubo-ovarian abcess or pelvic endometriosis or history of severe pelvic adhesions.
8. Psychiatric patients
9. Patient with chronic lung disease such as bronchial asthma, bronchiectasis, chronic obstructive pulmonary disease and interstitial lung disease

Minimum Eligible Age

30 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No